ロード中...
Efficacy and Tolerability of High-dose Escitalopram in Posttraumatic Stress Disorder
Open label trials suggest that escitalopram (up to 20mg/d) is an effective treatment for some, but not all posttraumatic stress disorder (PTSD) patients. Higher doses of escitalopram effectively reduced major depression symptoms in patients who had not responded to regular doses. The current study e...
保存先:
| 出版年: | J Clin Psychopharmacol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6446897/ https://ncbi.nlm.nih.gov/pubmed/27977469 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JCP.0000000000000626 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|